Skip to main content
Erschienen in: Journal of Endocrinological Investigation 1/2015

01.01.2015 | Opinion

Clinical Endocrinology in the near future: a post-modern challenge

verfasst von: F. Trimarchi

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Clinical Endocrinology is nowadays the clinical specialty specifically linked to translational research. Until the 1960s, endocrine clinical work-ups were based, especially in Europe, on bed-side examinations and on phenotype inspection, which was the main diagnostic tool for the diagnosis of endocrine disorders with a clinical approach strongly based on reductionism. Phenotype-based diagnosis might involve a decision delay with the risk that the organ or system damage could more often than not become irreversible. Thanks to advanced technologies, endocrinologists can now formulate a diagnosis and confirm it when the disorder is identified at a preclinical, rather than subclinical stage, without the obvious phenotypic features. The possibility of measuring very low amount of circulating chemical signals prior to and after the performance of provocative tests by stimulatory or inhibitory substances has detached Clinical Endocrinology from internal medicine, and endocrinologists have paid the price of a typical reductionist approach, as opposed to a holistic approach presumptuously adopted by non-endocrinologist internal medicine academics. …
Literatur
1.
Zurück zum Zitat Lamberts SWJ, Romijn JA, Wiersinga WM (2003) The future endocrine patient. Reflections on the future of clinical endocrinology. Eur J Endocrinol 149:169–175PubMedCrossRef Lamberts SWJ, Romijn JA, Wiersinga WM (2003) The future endocrine patient. Reflections on the future of clinical endocrinology. Eur J Endocrinol 149:169–175PubMedCrossRef
2.
Zurück zum Zitat Vigersky RA, Fish L, Hogan P, Stewart A, Kutler S, Ladenson PW, McDermott M, Hupartt K (2014) The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab. doi:10.1210/jc.2014-2257 Vigersky RA, Fish L, Hogan P, Stewart A, Kutler S, Ladenson PW, McDermott M, Hupartt K (2014) The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab. doi:10.​1210/​jc.​2014-2257
3.
Zurück zum Zitat Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW (2009) Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94:1853–1878PubMedCrossRef Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW (2009) Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94:1853–1878PubMedCrossRef
4.
Zurück zum Zitat Rotondi M, Coperchini F, Magri F, Chiovato L (2014) Serum-negative autoimmune thyroiditis: what’s in a name? J Endocrinol Invest 37:589–591PubMedCrossRef Rotondi M, Coperchini F, Magri F, Chiovato L (2014) Serum-negative autoimmune thyroiditis: what’s in a name? J Endocrinol Invest 37:589–591PubMedCrossRef
5.
Zurück zum Zitat Vignozzi L, Rastrelli G, Corona G, Gacci M, Forti G, Maggi M (2014) Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 37:313–322PubMedCrossRef Vignozzi L, Rastrelli G, Corona G, Gacci M, Forti G, Maggi M (2014) Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 37:313–322PubMedCrossRef
6.
Zurück zum Zitat Giuliani C, Cangioli M, Beck-Peccoz P, Faustini-Fustini M, Fiaccadori E, Peri A (2013) Awareness and management of hyponatraemia:the Italian hyponatraemia survey. J Endocrinol Invest 36:693–698PubMed Giuliani C, Cangioli M, Beck-Peccoz P, Faustini-Fustini M, Fiaccadori E, Peri A (2013) Awareness and management of hyponatraemia:the Italian hyponatraemia survey. J Endocrinol Invest 36:693–698PubMed
7.
Zurück zum Zitat Udelsman R, Zhang Y (2014) The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 24:472–479PubMedCrossRef Udelsman R, Zhang Y (2014) The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 24:472–479PubMedCrossRef
9.
Zurück zum Zitat Bartalena L, Fatourechi V (2014) Extathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest 37:691–700PubMedCrossRef Bartalena L, Fatourechi V (2014) Extathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest 37:691–700PubMedCrossRef
10.
Zurück zum Zitat Weetman AP (2012) The immunopathogenesis of chronic autoimmune thyroiditis. One century after Hashimoto. Eur Thyroid J 1:243–250PubMedCentralPubMed Weetman AP (2012) The immunopathogenesis of chronic autoimmune thyroiditis. One century after Hashimoto. Eur Thyroid J 1:243–250PubMedCentralPubMed
11.
Zurück zum Zitat Erfurth EM, Siesjö P, Eriksson T-B (2013) Pituitary disease mortality: is it a fiction? Pituitary 16:402–412PubMedCrossRef Erfurth EM, Siesjö P, Eriksson T-B (2013) Pituitary disease mortality: is it a fiction? Pituitary 16:402–412PubMedCrossRef
12.
Zurück zum Zitat Giustina A, Aimaretti G, Bondanelli M, Buzi M, Cannavò S, Cirillo S, Colao A, De Marinis LL, Ferone D, Gasperi M, Grottoli S, Porcelli T, Ghigo E, degli Uberti E (2010) Primary empty sella: why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest 33:343–346PubMedCrossRef Giustina A, Aimaretti G, Bondanelli M, Buzi M, Cannavò S, Cirillo S, Colao A, De Marinis LL, Ferone D, Gasperi M, Grottoli S, Porcelli T, Ghigo E, degli Uberti E (2010) Primary empty sella: why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest 33:343–346PubMedCrossRef
13.
Zurück zum Zitat Greenfield S, Kaplan SH, Kahn R, Ninomiya J, Griffith JL (2002) Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Int Med 136:114–121CrossRef Greenfield S, Kaplan SH, Kahn R, Ninomiya J, Griffith JL (2002) Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Int Med 136:114–121CrossRef
14.
Zurück zum Zitat Eisenberg JM (2002) Measuring quality: are we ready to compare the quality of care among physician groups? Ann Int Med 136:153–154PubMedCrossRef Eisenberg JM (2002) Measuring quality: are we ready to compare the quality of care among physician groups? Ann Int Med 136:153–154PubMedCrossRef
15.
Zurück zum Zitat Selye H (1976) Forty years of stress research: principal remaining problems and misconceptions. CMA J 115:53–57 Selye H (1976) Forty years of stress research: principal remaining problems and misconceptions. CMA J 115:53–57
16.
Zurück zum Zitat Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Roger P, Tabarin A (2003) Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinolo Metab 88:5808–5813CrossRef Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Roger P, Tabarin A (2003) Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinolo Metab 88:5808–5813CrossRef
17.
Zurück zum Zitat Terzolo M, Remondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, Limone P, Crivellaro C, Martinelli I, Montini M, Disoteo O, Ambrosi B, Lanzi R, Arosio M, Senni S, Balestrieri A, Solaroli E, Madeo B, De Giovanni R, Strollo F, Battista R, Scorsone A, Giagulli VA, Collura D, Scillitani A, Cozzi R, Faustini-Fustini M, Pia A, Rinaldi R, Allasino B, Peraga B, Tassone F, Garofalo P, Papini E, Borretta G (2012) Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J Clin Endocrinol Metab 97:2467–3475CrossRef Terzolo M, Remondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, Limone P, Crivellaro C, Martinelli I, Montini M, Disoteo O, Ambrosi B, Lanzi R, Arosio M, Senni S, Balestrieri A, Solaroli E, Madeo B, De Giovanni R, Strollo F, Battista R, Scorsone A, Giagulli VA, Collura D, Scillitani A, Cozzi R, Faustini-Fustini M, Pia A, Rinaldi R, Allasino B, Peraga B, Tassone F, Garofalo P, Papini E, Borretta G (2012) Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J Clin Endocrinol Metab 97:2467–3475CrossRef
18.
Zurück zum Zitat Tomlinson JW, Draper N, Mackie J, Johnson AP, Holder G, Wood P, Stewart P (2002) Absence of Cushingoid phenotype in a patient with Cushing’s disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab 87:57–62PubMed Tomlinson JW, Draper N, Mackie J, Johnson AP, Holder G, Wood P, Stewart P (2002) Absence of Cushingoid phenotype in a patient with Cushing’s disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab 87:57–62PubMed
20.
Zurück zum Zitat Heijmans BT, Tobi EW, Stein AB, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. PNAS 105:17046–17049PubMedCentralPubMedCrossRef Heijmans BT, Tobi EW, Stein AB, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. PNAS 105:17046–17049PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Roseboom T, de Rooij S, Painter R (2006) The Dutch famine and its long-term consequences for adult health. Early Human Dev 82:485–491CrossRef Roseboom T, de Rooij S, Painter R (2006) The Dutch famine and its long-term consequences for adult health. Early Human Dev 82:485–491CrossRef
22.
Zurück zum Zitat Braun T, Challis JR, Newnham JP, Sloboda DH (2013) Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk. Endocr Rev 34:885–916PubMedCrossRef Braun T, Challis JR, Newnham JP, Sloboda DH (2013) Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk. Endocr Rev 34:885–916PubMedCrossRef
23.
Zurück zum Zitat Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK (2012) Epigenetic transgenerational inheritance of altered stress responses. PNAS 109:9143–9148PubMedCentralPubMedCrossRef Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK (2012) Epigenetic transgenerational inheritance of altered stress responses. PNAS 109:9143–9148PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Hood L, Flores M (2012) A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New Biotechnol 29:613–624CrossRef Hood L, Flores M (2012) A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New Biotechnol 29:613–624CrossRef
25.
Zurück zum Zitat Ahn AC, Tewari M, Poon C-S, Phillips RS (2006) The limits of reductionism in medicine: could systems biology offer an alternative? Plos Med 3:709–713 Ahn AC, Tewari M, Poon C-S, Phillips RS (2006) The limits of reductionism in medicine: could systems biology offer an alternative? Plos Med 3:709–713
26.
Zurück zum Zitat Ahn AC, Tewari M, Poon C-S, Phillips RS (2006) The clinical applications of a systems approach. Plos Med 3:956–960 Ahn AC, Tewari M, Poon C-S, Phillips RS (2006) The clinical applications of a systems approach. Plos Med 3:956–960
Metadaten
Titel
Clinical Endocrinology in the near future: a post-modern challenge
verfasst von
F. Trimarchi
Publikationsdatum
01.01.2015
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 1/2015
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0181-7

Weitere Artikel der Ausgabe 1/2015

Journal of Endocrinological Investigation 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.